FIRSTSTRING RESEARCH, LLC

Company Information

Company Name
FIRSTSTRING RESEARCH, LLC
Address
300 West Coleman Blvd.
Mt. Pleasant, SC, 29464-3429
Phone
n/a
URL
n/a
DUNS
602545654
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$522,752.00
3
SBIR Phase II
$3,634,174.00
2
STTR Phase I
$152,255.00
1
Chart code to be here

Award List

  1. Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds

    Amount: $641,088.00

    DESCRIPTION (provided by applicant): According to the American Diabetes Association, there are more than 16 million people in the United States with known diabetes. Diabetic patients commonly demonstr ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Restoration of Skin Structure and Function Post-Wounding

    Amount: $152,255.00

    DESCRIPTION (provided by applicant): The wound repair process in skin is initiated immediately after an injury and induces a cascade of events including inflammation, proliferation, and scar productio ...

    STTR Phase I 2006 Department of Health and Human Services
  3. Evaluation of a novel connexin-based peptide for the treatment of diabetic wounds

    Amount: $141,189.00

    DESCRIPTION (provided by applicant): According to the American Diabetes Association, there are more than 16 million people in the United States with known diabetes. Diabetic patients commonly demonst ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. SBIR Phase I: Novel Connexin-Based Peptide for the Treatment of Age-Related Macular Degeneration

    Amount: $148,803.00

    This Small Business Innovation Research (SBIR) Phase I project is a feasibility assessment of the ocular delivery of a synthetic peptide, ACT1, for the treatment of Age-Related Macular Degeneration (A ...

    SBIR Phase I 2012 National Science Foundation
  5. Development of a novel connexin-based peptide for the treatment of corneal injury

    Amount: $232,760.00

    DESCRIPTION (provided by applicant): According to the World Health Organization, at least 171 million people worldwide are living with diabetes and this figure is likely to more than double by the yea ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds

    Amount: $2,993,086.00

    Project Summary/Abstract According to the ADA, 25.8 million children and adults have diabetes. Diabetics have an increased risk of complications such as heart disease and are prone to impaired wound ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government